Kestra Medical Technologies, Ltd. Common Stock (KMTS) Q2 2024 Earnings
KMTS·Reported April 30, 2024·After market close
Kestra Medical Technologies, Ltd. Common Stock reported Q2 2024 revenue of $10.1M. Diluted EPS came in at $-0.45.
Revenue
$10.1M
Diluted EPS
$-0.45
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about Kestra Medical Technologies, Ltd. Common Stock's Q2 2024 earnings report.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) reported Q2 2024 earnings on April 30, 2024 after market close.
Kestra Medical Technologies, Ltd. Common Stock reported revenue of $10.1M and diluted EPS of $-0.45 for Q2 2024.